Literature DB >> 9463772

Reaching closure with skin stretching. Applications in the diabetic foot.

D G Armstrong1, R P Wunderlich, L A Lavery.   

Abstract

At the present time, there are no evidence-based protocols outlining the use of the Sure-Closure Skin Stretching System on diabetic, neuropathic wounds. Ideally, surgical correction of the precipitating deformity and appropriate shoe gear accommodation should be performed con-comitantly with skin stretching (as indicated) to achieve an optimal long-term result. For several years, we have used the Sure-Closure device as an adjunctive treatment for diabetic-foot wound closure, and believe that, ultimately, this device more likely will be used in a clinical setting. In this manner, a patient with an open wound may, under aseptic conditions, be sequestered for a period of 1 to 2 hours during a clinical visit to allow for skin stretching. This procedure may be carried out two or three times weekly until closure is achieved. Mechanically assisted delayed primary closure is a relatively new category of wound closure; however, this device is by no means a panacea. Appropriate patient selection and intraoperative judgment are of critical preoperative and perioperative importance when employing this technique. Currently, we are completing a clinical trial comparing mechanically assisted delayed primary-wound closure to traditional treatment and off-loading in a population of high-risk diabetic patients. We believe that this project will better elucidate the relative indications and contraindications with what may be a very effective tool for the diabetic foot specialist.

Entities:  

Mesh:

Year:  1998        PMID: 9463772

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  1 in total

1.  Application of a simple skin stretching system and negative pressure wound therapy in repair of complex diabetic foot wounds.

Authors:  Yaojun Wu; Liang Chen; Shaokun Wu; Liying Yu; Mimi Chen; Jingnan Wang; Jiejie Chen; Qingjiang Pang
Journal:  J Orthop Surg Res       Date:  2021-04-14       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.